Rating: HOLD | 12-Month Price Target: $300 | Conviction: High
Texas Instruments is executing the operating recovery correctly: Q3 2026 revenue increased 28% year over year, gross margin rebounded to 64.2%, and operating margin reached 47.5% as stronger factory loading converted incremental revenue into disproportionate profit. Analog revenue increased 32%, Embedded Processing grew 21%, and management guided Q4 revenue to $5.80-$6.30 billion with EPS of $2.45-$2.79. (sec.gov)
The investment problem is not business quality; it is price versus normalized economics. At $309.83, TXN trades at approximately 40.1 times trailing GAAP earnings and roughly 34 times our estimated FY2026 EPS. The stock is only about 7% below its 52-week high despite unresolved questions around cycle durability, the subsidy content of free cash flow, persistent inventory intensity and the $7.5 billion Silicon Labs integration. (bloomberglinea.com)
Our $300 target reflects a high-quality franchise deserving a premium multiple, but not an unlimited one. The current valuation requires sustained double-digit revenue growth, continued gross-margin recovery, disciplined post-2026 capital expenditures and successful Silicon Labs integration. The expected 12-month total return, including the annualized $6.08 dividend, is approximately -1.2%, inadequate for initiating or enlarging a position.
| Measure | Value |
|---|---|
| Reference price | $309.83 |
| 12-month target price | $300.00 |
| Implied price return | -3.2% |
| Forward annual dividend | $6.08 |
| Dividend yield | 2.0% |
| Implied total return | -1.2% |
Texas Instruments designs and manufactures analog and embedded-processing semiconductors. The business is unusually broad and diversified, serving more than 100,000 customers, with approximately half of revenue generated outside the largest 50 customers. More than 80% of 2025 revenue was transacted through direct channels, including TI.com, reducing distributor dependence and increasing visibility into customer designs, pricing and inventory. (sec.gov)
Q3 2026 segment composition was:
| Segment | Revenue | % of Total | YoY Growth | Operating Margin |
|---|---|---|---|---|
| Analog | $4.91B | 81.1% | 32% | 51.0% |
| Embedded Processing | $0.86B | 14.2% | 21% | 26.5% |
| Other | $0.29B | 4.7% | (6%) | 49.7% |
| Total | $6.06B | 100% | 28% | 47.5% |
Analog includes power-management and signal-chain products. Embedded Processing primarily includes microcontrollers and processors. Other includes DLP products, calculators and certain ASICs, as well as corporate-level charges and gains. (sec.gov)
The 2025 end-market mix was approximately 33% industrial, 33% automotive, 21% personal electronics, 9% data center, 3% communications equipment and 1% calculators. This mix provides diversification but leaves two-thirds of revenue exposed to industrial and automotive capital cycles. (sec.gov)
TI’s moat consists of four mutually reinforcing elements:
The economic advantage is real, but it is conditional on utilization. Internal manufacturing converts variable foundry costs into fixed depreciation and operating costs. When demand weakens, underutilization compresses margins sharply; when demand recovers, the same structure produces powerful incremental margins. TI explicitly identifies factory loading as a major determinant of profitability. (sec.gov)
CEO Haviv Ilan has preserved TI’s owner-oriented emphasis on long-term free cash flow per share. Management completed the bulk of its elevated fabrication investment cycle and reduced expected 2026 capital expenditures to $2-$3 billion, versus substantially higher spending during 2023-2025. Through the first nine months of 2026, gross capital expenditures were $1.65 billion. (sec.gov)
Julie Knecht became CFO effective August 1, 2026, succeeding Rafael Lizardi. She had served at TI for more than 25 years, most recently as chief accounting officer. The company expressly stated that Lizardi’s retirement was unrelated to financial performance, reporting practices or internal controls. (investor.ti.com)
Executive alignment is substantial but imperfect. Ilan’s 2025 equity award had an $18 million grant-date value, split equally between restricted stock units and options. RSUs cliff-vest after four years, while options require stock-price appreciation. Hedging and pledging by directors and executive officers are prohibited. Nevertheless, compensation remains heavily equity-linked and therefore can reward multiple expansion independently of per-share cash-flow quality. (sec.gov)
Institutional ownership is structurally significant: Vanguard reported approximately 10.0% ownership and BlackRock 8.5% in the 2026 proxy. A meaningful portion is likely index- and benchmark-driven rather than an expression of active fundamental conviction. (sec.gov)
Retail sentiment appears anchored to three narratives: dividend growth, “American-made” semiconductor capacity and AI/data-center exposure. That framing is directionally valid but incomplete. Data center represented only 9% of 2025 revenue, while industrial and automotive remained the dominant economic exposures.
Sell-side sentiment has become increasingly constructive following the earnings recovery. One current compilation showed a Buy consensus and a $336.86 average target, but the wide $250-$400 range demonstrates that analysts disagree materially on normalized earnings and the appropriate premium multiple. (stockanalysis.com)
Q3 results showed broad demand recovery across end markets and regions. Revenue grew 11% sequentially and 28% year over year, with strength in industrial, automotive and data center. Gross margin improved 680 basis points year over year and operating margin expanded 1,240 basis points. (investor.ti.com)
Q4 guidance implies revenue of approximately $6.05 billion and EPS of $2.62 at the midpoint. If achieved, FY2026 revenue would approach $22.4 billion and EPS approximately $9.06, representing a powerful recovery from FY2025 revenue of $17.68 billion and diluted EPS of $5.45. (investor.ti.com)
On February 4, 2026, TI agreed to acquire Silicon Labs for $231 per share in cash, implying enterprise value of approximately $7.5 billion. The strategic rationale is credible: Silicon Labs contributes approximately 1,200 wireless-connectivity products, and TI intends to migrate external-foundry production into its internal 300mm and assembly/test infrastructure. Management forecasts at least $450 million of annual manufacturing and operating synergies within three years and EPS accretion in the first full year after closing, excluding transaction expenses. Closing is expected in the first half of 2027, subject to regulatory approvals and other conditions. (investor.ti.com)
The purchase price is aggressive. Based on Silicon Labs’ indicated 2025 revenue of approximately $785 million, TI is paying roughly 9.6 times revenue before synergies. The $450 million synergy target equals approximately 57% of the target’s revenue, leaving limited tolerance for integration delays, customer attrition, manufacturing-transfer setbacks or regulatory remedies.
TI priced $2.0 billion of senior unsecured notes on October 26, 2026, across maturities from 2028 to 2036 and coupons from 5.00% to 5.75%. Proceeds are earmarked for the Silicon Labs acquisition. The weighted-average coupon is approximately 5.4%, creating roughly $108 million of incremental annual pre-tax interest expense. (investor.ti.com)
The company also has a $5 billion delayed-draw term-loan facility conditioned on completion of the acquisition. No amount was outstanding as of September 30. (sec.gov)
At $309.83, TXN is approximately 7% below its indicated 52-week high of roughly $334 and more than double its 52-week low. It stands near the upper end of the annual range after a rapid re-rating alongside the earnings recovery. (bloomberglinea.com)
Current GAAP P/E comparisons are distorted by different positions in the analog cycle. TXN trades near 40 times trailing earnings, versus approximately 51 times for Analog Devices, 20 times for NXP, and roughly 50 times for onsemi; Microchip’s reported P/E exceeds 100 times because its trailing earnings remain cyclically depressed. These figures reinforce the need to value the group on normalized forward earnings and cash flow rather than spot GAAP P/E alone.
The Federal Reserve held the federal-funds target range at 3.75%-4.00% on October 28, 2026. It characterized economic growth as strong but inflation as elevated; two voting members preferred another 25-basis-point increase. Higher-for-longer rates pressure industrial capital spending, auto affordability and long-duration equity multiples while raising the cost of acquisition financing. (federalreserve.gov)
September CPI rose 3.7% year over year, while core CPI increased 2.6%. Industrial production increased 2.2% year over year, and Q3 industrial production grew at a 2.8% annualized rate, supporting TI’s cyclical recovery. Capacity utilization, however, remained 2.5 percentage points below its long-run average, indicating that the wider industrial economy is improving but not operating at scarcity conditions. (bls.gov)
The direct implications are mixed:
| Fiscal Year | Revenue | Gross Margin | Operating Margin | Net Income | Diluted EPS |
|---|---|---|---|---|---|
| 2023 | $17.52B | 62.9% | 41.8% | $6.51B | $7.07 |
| 2024 | $15.64B | 58.1% | 34.9% | $4.80B | $5.20 |
| 2025 | $17.68B | 57.0% | 34.1% | $5.00B | $5.45 |
| 9M 2026 | $16.34B | 61.4% | 42.8% | $5.95B | $6.44 |
Historical figures are from filed financial statements. (sec.gov)
Earnings quality is generally high: revenue is product-based, customer concentration is low, receivables remain well controlled, and there is no material reliance on fair-value gains, capitalized development spending or acquisition accounting. Q3 DSO was 39 days versus 40 at year-end 2025 despite a $657 million increase in receivables, indicating that the receivable build broadly tracked revenue. (sec.gov)
The principal earnings-quality issue is cyclical operating leverage, not accounting fraud. A large portion of Q3 margin expansion came from absorbing fixed manufacturing costs over greater output. This is genuine profit, but not necessarily steady-state profit.
TI defines free cash flow as:
Operating cash flow less capital expenditures, plus direct CHIPS Act incentive proceeds.
For the twelve months ended September 30, 2026:
| Cash-flow measure | Amount |
|---|---|
| Operating cash flow | $9.90B |
| Less: capital expenditures | ($2.58B) |
| Conventional CFO less capex | $7.32B |
| Add: direct CHIPS proceeds | $1.10B |
| TI-reported FCF | $8.42B |
| Less: CHIPS ITC embedded in CFO | ($0.47B) |
| Fully subsidy-adjusted FCF | $6.85B |
The company’s calculation is disclosed and internally consistent, but direct grants should not be capitalized at the same multiple as recurring operating cash generation. Both direct incentives and tax credits are economically valuable; they are not evidence of misconduct. They are, however, policy-dependent cash inflows associated with a finite construction program. (investor.ti.com)
Inventory was $4.67 billion at September 30, comprising $497 million of raw materials, $2.48 billion of work in process and $1.69 billion of finished goods. Inventory fell $132 million from year-end, and days of inventory declined to 194 from 222. (sec.gov)
The composition is defensible because analog products have long lives and low obsolescence risk, while work-in-process supports customer service and manufacturing flexibility. Nonetheless, 194 days remains a material cash commitment. The bear-case risk is not a conventional fashion-driven write-down; it is prolonged balance-sheet drag, reduced pricing flexibility and slower factory loading if customers pause replenishment.
As of September 30, 2026:
All existing funded debt is unsecured, with maturities distributed from 2027 through 2063. Near-term refinancing requirements are manageable: $1.15 billion matures in 2027 and $700 million in 2028 before inclusion of the newly issued acquisition notes. (sec.gov)
After issuing the $2 billion notes and completing the $7.5 billion acquisition, pro forma net debt could approach approximately $13 billion, depending on closing cash generation and the final mix of cash and term-loan funding. This remains serviceable against recovering cash flow, but it meaningfully reduces optionality for aggressive repurchases or another major acquisition.
For the first nine months of 2026, TI generated $7.64 billion of operating cash flow, spent $1.65 billion on capital expenditures, received $1.10 billion of direct CHIPS proceeds, paid $3.88 billion in dividends and repurchased $233 million of stock. (sec.gov)
The dividend is covered, but the degree of coverage depends on treatment of subsidies:
| Coverage Measure | Coverage of $5.17B TTM Dividends |
|---|---|
| TI-reported FCF | 1.63x |
| Conventional CFO less capex | 1.41x |
| Subsidy-adjusted FCF | 1.32x |
The dividend is not presently at risk. Its growth rate, however, may be constrained by acquisition financing and normalization of government-related cash benefits.
Share repurchases have become secondary. Over the trailing twelve months TI repurchased $636 million while paying $5.17 billion in dividends. In the first nine months of 2026, proceeds from employee common-stock transactions were $770 million versus $233 million spent on repurchases. Diluted shares increased from 914 million in 9M 2025 to 918 million in 9M 2026, meaning repurchases did not offset equity issuance. (investor.ti.com)
That dilution is small, but directly conflicts with the company’s stated objective of maximizing free cash flow per share. The board retains $18.56 billion of repurchase authorization, yet authorization size is economically irrelevant unless purchases exceed issuance and are executed below intrinsic value. (sec.gov)
Our $300 target triangulates four methodologies.
We estimate FY2027 EPS of approximately $11.20, assuming:
Applying 28 times forward EPS produces a value of $314. The multiple embeds a premium for 300mm economics, portfolio breadth, customer diversification and long product lives, while remaining below the current trailing multiple.
We estimate 2027 EBITDA of approximately $12.6 billion, including partial Silicon Labs contribution and initial synergies. Applying a premium 23 times EV/EBITDA yields enterprise value near $290 billion.
After deducting approximately $13 billion of pro forma net debt and dividing by approximately 914 million shares, the methodology produces equity value of approximately $303 per share.
This approach is relatively generous: a 23-times multiple assumes that TI’s capital intensity has structurally peaked and that the current recovery does not reverse.
Our FCFE model assumes:
The resulting value is approximately $278 per share. This model is highly sensitive to the spread between discount rate and terminal growth. A 50-basis-point reduction in the discount rate or increase in terminal growth would add roughly $30-$45 per share, illustrating how much duration is embedded in TXN’s valuation.
Starting with the annualized dividend of $6.08, we assume:
The resulting value is approximately $289 per share. This methodology recognizes TI’s dividend durability but penalizes the stock for its sub-2% starting yield and acquisition-related constraints on near-term payout growth.
| Method | Value | Weight |
|---|---|---|
| Forward P/E | $314 | 35% |
| EV/EBITDA | $303 | 25% |
| DCF | $278 | 30% |
| Dividend discount | $289 | 10% |
| Weighted value | $298 | 100% |
| Rounded target | $300 |
The $300 target implicitly grants TXN a substantial quality premium. No additional conglomerate or scarcity premium is warranted because the stock already trades near the top of its 52-week range, and the Silicon Labs transaction introduces incremental execution risk.
| Scenario | Key Conditions | 12-Month EPS Basis | Multiple | Price Target |
|---|---|---|---|---|
| Bear | Industrial orders flatten; GM falls below 61%; acquisition delayed; subsidy-adjusted FCF below $7B | $8.50 | 26x | $220 |
| Base | Revenue growth normalizes; GM remains 63%-65%; capex discipline offsets higher interest; deal progresses | $10.70-$11.20 | 27x-28x | $300 |
| Bull | Data center and industrial remain strong; GM exceeds 66%; Silicon Labs synergies de-risk; FCF exceeds $10B | $12.50 | 30x | $375 |
The probability-weighted distribution is unfavorable at $309.83: upside requires both earnings delivery and continued premium valuation, while the bear case can emerge from either operational disappointment or multiple compression alone.
The base-case HOLD may still be too generous.
First, the market may be capitalizing a cyclical snapback as secular growth. Q3’s extraordinary profit conversion is not a normalized margin framework; it reflects a recovering fixed-cost manufacturing base, depressed prior-period utilization and a restructuring charge in the comparator. If revenue growth decelerates from 28% to low single digits, incremental margins can reverse quickly.
Second, the reported $8.4 billion of trailing free cash flow overstates internally generated recurring cash capacity. Approximately $1.1 billion came from direct CHIPS proceeds, and another $469 million of tax-credit benefits was embedded in operating cash flow. Removing both reduces FCF by nearly 19%. The market is therefore paying more than 41 times fully subsidy-adjusted trailing FCF.
Third, inventory remains a latent duration risk. Analog inventory does not necessarily become obsolete quickly, but “long-lived” is not synonymous with “liquid.” TI has tied up $4.67 billion in inventory while simultaneously building manufacturing capacity. A weak order environment would force the company to choose between elevated inventory, underutilized factories and price concessions.
Fourth, the Silicon Labs transaction may be an admission that TI’s organic embedded strategy lacks sufficient wireless differentiation. Paying approximately 9.6 times target revenue and forecasting annual synergies equal to 57% of that revenue is aggressive. The strategic logic depends on manufacturing migration, but semiconductor process transfers require customer qualification, engineering resources and execution over multiple years. Synergy realization may lag interest expense and purchase-accounting dilution.
Fifth, the company’s shareholder-return narrative has weakened. Dividends dominate capital returns, repurchases have fallen sharply, and diluted share count is rising. TI can credibly claim to return cash to shareholders while still failing to grow cash flow per share if equity compensation exceeds repurchase activity.
Sixth, the valuation offers almost no margin of safety. The stock is near its 52-week high, the current dividend yield is below 2%, and the implied earnings multiple assumes that 300mm cost advantages will not be competed away through price. Chinese analog suppliers, mature-node capacity additions and customer dual-sourcing could cause TI’s manufacturing savings to accrue partly to customers rather than shareholders.
Finally, the balance sheet is transitioning from conservatively levered to acquisition-dependent. The $2 billion note issuance is only part of the Silicon Labs funding package. Higher leverage is manageable during an upswing but becomes strategically restrictive if the industrial cycle turns, rates remain elevated or regulatory approval is delayed after financing costs have already been incurred.
Red-team conclusion: Texas Instruments remains an exceptional company, but at $309.83 it can become a value trap in quality-stock clothing—an investor may own a superior franchise while earning an inferior return because cycle recovery, government support, manufacturing leverage and acquisition success are already embedded in the price. A compelling entry requires either a decline toward $250-$270 or evidence that sustainable post-acquisition EPS exceeds $12 without sacrificing balance-sheet flexibility.